The Latest
CCAGW Urges Leaders of House Committee on Oversight and Government Reform to Support H.R. 5749, H.R. 5457, and H.R. 143
Stronger oversight bills will help track official time costs, cut duplicative software spending, and sunset unauthorized programs.
CCAGW Joins Coalition Opposing the Increase in FDIC Deposit Insurance Limits
Raising FDIC insurance limits for business accounts imposes high costs, risks moral hazard, and harms consumers.
Committee Hearing Should End Calls for Deposit Insurance Increase
Bank failures were caused by mismanagement and poor oversight and no level of deposit insurance would have stopped their demise.
TestimonyTestimony Before the House Committee on Financial Services on Deposit Insurance
Raising FDIC insurance limit to $10 million will increase risk, moral hazard, and taxpayer burden instead of preventing bank failures. Banking industry needs better oversight, not raised guarantees.
CCAGW Urges Leaders of House of Representatives and Senate Armed Services Committees to Oppose Section 1564 in S. 2296
NDAA Section 1564 lets Department of Defense veto any attempts to obtain spectrum for non-military uses, hindering telecom.
CCAGW Urges Ohio Senators to Oppose SB 198
SB 198 would change how the federal 340B Drug Discount Program operates in the Buckeye State
“Most Favored Nation” Implementation Expands Dangerous CMMI Authority
Washington, D.C.
CCAGW Urges Ohio Representatives to Oppose HB 276
HB 276 would change how the federal 340B Drug Discount Program operates in Ohio.
CCAGW Urges House of Representatives to Support Overturning Improper Use of E-Rate Funds
S.J. Res.7 blocks the FCC’s E-Rate expansion, which misuses funds, raises taxes, and exceeds the program’s intent.
CCAGW Urges Senate to Oppose the CMMI Models That Use MFN Pricing
Using Center for Medicare and Medicaid Innovation to test Most Favored Nation pricing combines failed agency with bad policy.
CCAGW Urges House of Representatives to Oppose the CMMI Models That Use MFN Pricing
Using Center for Medicare and Medicaid Innovation to test Most Favored Nation pricing combines failed agency with bad policy.
TestimonyTestimony Before the Senate Health, Education, Labor and Pensions Committee on 340B
The 340B Drug Discount Program has drifted from its original mission of helping patients. The reforms promoted by CCAGW and the Senate HELP Committee majority staff report would fix 340B and restore the program to its original mission.




